Abstract
Randomized controlled trials (RCTs) are the gold-standard data source for National Institute for Care and Health Excellence (NICE) appraisals; however, it is possible that their results might not be generalizable to patients seen in clinical practice. This research aimed to evaluate the extent of real-world evidence (RWE) use in NICE submissions for oncology in the United Kingdom (UK).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
